AI, Amyotrophic Lateral Sclerosis, Angel Investing, Cognition and Learning, Depression and the pursuit of mental health, Digital Health, Executive Function, Health 2.0, Humanitarian Efforts, Neuropsychology, Online Communities, Public Health, Rare Diseases
2013
United Kingdom
Wicks Digital Health; WDH Investments Ltd; Leighton Park School; RunYourself; Durham University; Wellington College; King's College London; Institute of Psychiatry; Ventures Together; PatientsLikeMe; Sano Genetics; Ada Health; TED Conferences; Quantic School of Business and Technology; Woebot Health
Investing up to £10k in Pre-seed - Series A (with potential for follow-on) in UK / EU-based companies that have the potential to dramatically improve patient outcomes by enabling the digital health backbone.
Investments include: BlueSkye AI, EarSwitch, Sano Genetics, Una Health // TED Fellows program handpicks world-changing innovators from around the globe and brings them to the TED stage -- literally and figuratively -- to raise international awareness of their remarkable work.http://www.ted.com/fellows // R&D Director; coordinating team of 6 staff in developing new communities, carrying out research, liaising with industry, non-profits and academia, answering patient queries, representing company at conferences and in media, writing blog posts, selection and training of staff, statistical analysis and submitting articles for peer-review journals. // Postdoc on a project funded by the Parkinson's Disease Society investigating "Mood and Emotion in Parkinson's disease". Project lead on the MindSearch volunteer database. // PhD investigating cognitive dysfuntion in people with amyotrophic lateral sclerosis, also known as motor neurone disease or Lou Gehrig's disease. Included research into rare subgroups such as Familial ALS/MND, progressive muscular atrophy, and primary lateral sclerosis. Webmaster at www.build-uk.net. Chair of IOP Student Forum (2004) // Wicks Digital Health; WDH Investments Ltd; Leighton Park School; RunYourself; Durham University; Wellington College; King's College London; Institute of Psychiatry; Ventures Together; PatientsLikeMe; Sano Genetics; Ada Health; TED Conferences; Quantic School of Business and Technology; Woebot Health // Paul Wicks is an experienced professional with a background in investing in UK/EU-based companies focused on digital health solutions to enhance patient outcomes. With a keen eye for potential, he has made strategic investments in companies like BlueSkye AI, EarSwitch, Sano Genetics, and Una Health. Paul has also demonstrated his expertise as an R&D Director, leading a team in various activities such as research, industry collaboration, and patient engagement. His academic background includes postdoctoral work on Parkinson's disease and a PhD focusing on cognitive dysfunction in individuals with amyotrophic lateral sclerosis. Paul's diverse skill set encompasses statistical analysis, publication in peer-reviewed journals, and web management, showcasing his versatility in both scientific and business domains. // I want to make a world where everybody living with a medical condition can learn from the synthesised wisdom of everyone else who has been where they've been, and contribute their own lived experience in a way that advances science and medicine // Paul Wicks is a seasoned professional with a strong background in investing in UK/EU-based companies specializing in digital health solutions aimed at improving patient outcomes. His strategic investments in companies like BlueSkye AI, EarSwitch, Sano Genetics, and Una Health underscore his keen eye for promising ventures. Beyond his investment acumen, Paul has excelled as an R&D Director, leading teams in research, industry collaborations, and patient engagement initiatives. His academic pursuits, including postdoctoral work on Parkinson's disease and a PhD focusing on cognitive dysfunction in individuals with amyotrophic lateral sclerosis, highlight his expertise in the healthcare domain. With a diverse skill set encompassing statistical analysis, publication in peer-reviewed journals, and web management, Paul demonstrates versatility across scientific and business realms. // Medical architect // British medical entrepreneur and lead scientist for PatientsLikeMe, an online community allowing people living with medical conditions to track their illnesses, share their experiences and contribute to research.
Paul Wicks, Ph.D., is VP of Innovation at PatientsLikeMe. Specialising in the conduct of clinical research using the Internet, Paul is responsible for shaping the scientific validity of the PatientsLikeMe platform. He leads a team of experts charged with conducting scientific research that generates insights from the personal health data shared by patient members.
Under Paul’s direction, his team has produced over fifty peer-reviewed publications including an innovative patient-led observational trial of lithium in ALS, novel patient-reported outcomes for people with multiple sclerosis, and a study of the potential for improved patient outcomes through connecting with one another. The team’s academic collaborators include Johns Hopkins, Harvard Medical School, MIT, Oxford University, the VA’s Epilepsy Centers of Excellence, and ALS Untangled. The R&D team also provides professional services to the company’s commercial partners, comprising most of top 20 pharma.
Prior to joining PatientsLikeMe, Paul worked directly with patients at the Institute of Psychiatry (King’s College London) studying cognition in rare forms of ALS and the psychological consequences of Parkinson’s disease. Paul was awarded "TR35 Humanitarian of the Year" by MIT's Technology Review magazine and is a TED Fellow.
// Paul Wicks, Ph.D., is Vice President of Innovation at PatientsLikeMe. Specialising in the conduct of clinical research using the Internet, Paul is responsible for shaping the scientific validity of the PatientsLikeMe platform. He leads a team of experts charged with conducting scientific research that generates insights from the personal health data shared by patient members.
Under Paul's direction, his team has produced over 100 peer-reviewed publications in journals such as Nature Biotechnology, the BMJ, and Neurology. Highlights include ALS clinical trials conducted over the Internet, dozens of new outcome measures, and realizing the potential benefits of patients connecting with one another.
The team's academic collaborators have included Johns Hopkins, Harvard Medical School, MIT, Oxford University, King's College London, the VA, and ALSUntangled. The team also provides professional services to the company's commercial partners including every major pharmaceutical manufacturer.
Today PatientsLikeMe forms part of the Digital Health Alliance launched by Chinese AI company iCarbonX in January of 2017 by TED 2017 speaker Jun Wang.
Prior to joining PatientsLikeMe, Dr. Wicks worked directly with patients at the Institute of Psychiatry (King's College London) studying cognition in rare forms of ALS and the psychological consequences of Parkinson's disease. Paul was awarded "TR35 Humanitarian of the Year" by MIT's Technology Review magazine, recognised as one of Britain's 50 "New Radicals" by The Observer and NESTA, and is a TED Fellow from the class of 2013. // Paul Wicks is a seasoned professional with a strong background in investing in UK/EU-based companies specializing in digital health solutions aimed at improving patient outcomes. His strategic investments in companies like BlueSkye AI, EarSwitch, Sano Genetics, and Una Health underscore his keen eye for promising ventures. Beyond his investment acumen, Paul has excelled as an R&D Director, leading teams in research, industry collaborations, and patient engagement initiatives. His academic pursuits, including postdoctoral work on Parkinson's disease and a PhD focusing on cognitive dysfunction in individuals with amyotrophic lateral sclerosis, highlight his expertise in the healthcare domain. With a diverse skill set encompassing statistical analysis, publication in peer-reviewed journals, and web management, Paul demonstrates versatility across scientific and business realms. // Medical architect // technology, health 2.0, public health, lithium, als, data, energy storage, job skills training, executive function, medical research, research, volunteerism, neurology, medical publishing, digital health, amyotrophic lateral sclerosis, humanitarian, cognition and learning, data analysis, neuropsychology, biotech, telegenetics, online communities, nature, battery, depression and the pursuit of mental health, startups, science, angel investing, artificial intelligence, rare disease, disease // Lichfield|England|United Kingdom|Alrewas
Lichfield|England|United Kingdom|Alrewas